Tax Issues in the Proposed Pfizer-AstraZeneca Merger : CRS Insight.

Format:

Book

Government document

Author/Creator:

Library of Congress. Government Division.

Language:

English

Subjects (All):

Corporations--Taxation.

Corporations.

Occupations.

International finance.

Great Britain.

Physical Description:

1 online resource (1 online resource (2 p), digital, PDF file)

Place of Publication:

[Place of publication not identified] : [publisher not identified], 2014.

System Details:

text file

Summary:

Addresses tax issues in proposed takeover of British AstraZeneca by Pfizer, a major U.S. pharmaceutical company, which would benefit the company by taking advantage of British tax laws. Considers general concerns about U.S. firms shifting headquarters abroad for tax purposes, and whether U.S. corporate tax policy reform would be beneficial to retain U.S. corporations and jobs.

Notes:

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Sept. 2014). Reuse except for individual research requires license from ProQuest, LLC.

CRS Report.

Other Format:

Microfiche version: Library of Congress. Government Division. Tax Issues in the Proposed Pfizer-AstraZeneca Merger

Access Restriction:

Restricted for use by site license.